up to 261,895 new shares can be issued upon the exercise of 90,780 share options that are still outstanding under the 'Executive Share Options' plan for staff members and consultants of the Company, ...

Abstract: As networks advance toward the Sixth Generation (6G), management of high-speed and ubiquitous connectivity poses major challenges in meeting diverse Service Level Agreements (SLAs). The Zero ...

Panelists discuss how diuretics serve as necessary “bailout therapy” for volume management in heart failure but should not substitute for guideline-directed medical therapy, with emerging evidence ...

For weeks earlier this year, the Army’s top uniformed lawyer had been raising legal concerns inside the Pentagon about some of the new policies being rolled out dictating how the military can be used ...

Loop went 1-for-2 on field-goal attempts and made his only PAT in Sunday's 44-10 loss to the Texans. Loop connected on a chip-shot 27-yard field goal in the first quarter before later missing a ...

What Is Enbumyst, and Why Does It Matter? Enbumyst is a new nasal spray form of bumetanide (first approved by the FDA in 1983). It is a type of medicine called a loop diuretic (also known as a “water ...

The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease patients, aiming to prevent a common and costly issue that results in more than ...

Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, demonstrated consistent efficacy and safety regardless of diuretic type or dose and reduced overall diuretic requirements in patients ...

A new analysis suggests that finerenone (Kerendia), a newer heart failure medication, may help older adults rely less on high doses of water pills. The findings come from the large FINEARTS-HF ...

Finerenone reduced heart failure events and cardiovascular deaths in patients with HFmrEF or HFpEF when used with diuretics. The study found finerenone reduced hypokalemia risk but increased ...

Review publication details benefits of repetitive transcranial magnetic stimulation (rTMS) on Alzheimer’s, including increases in neuroplasticity and other structural and functional second order ...